M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Other Current Liabilities Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Other Current Liabilities
€369k
CAGR 3-Years
75%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other Current Liabilities
€29.9m
CAGR 3-Years
-56%
CAGR 5-Years
19%
CAGR 10-Years
21%
G
Genfit SA
PAR:GNFT
Other Current Liabilities
€6.3m
CAGR 3-Years
76%
CAGR 5-Years
18%
CAGR 10-Years
1%
Inventiva SA
PAR:IVA
Other Current Liabilities
€3.7m
CAGR 3-Years
17%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Other Current Liabilities
€18.7m
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
23%
OSE Immunotherapeutics SA
PAR:OSE
Other Current Liabilities
€2.9m
CAGR 3-Years
-8%
CAGR 5-Years
-25%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Other Current Liabilities?
Other Current Liabilities
369k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Other Current Liabilities amounts to 369k EUR.

What is Maat Pharma SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
18%

Over the last year, the Other Current Liabilities growth was -16%. The average annual Other Current Liabilities growth rates for Maat Pharma SA have been 75% over the past three years , 18% over the past five years .

Back to Top